# Genome and drug resistance analysis of Mycobacterium abscessus complex on tropical islands in China

**Authors:** Jieying Wang, Chunrong Li, Xianliang Zheng, Zhuolin Chen, Wen Ye, Yuni Xu, Wenhua Qiu, Shaowen Chen, Hua Pei, Yeteng Zhong

PMC · DOI: 10.3389/fmicb.2026.1702466 · Frontiers in Microbiology · 2026-02-04

## TL;DR

This study analyzes the genetic diversity and drug resistance of Mycobacterium abscessus complex in Hainan, China, to improve clinical diagnosis and treatment.

## Contribution

The study provides new insights into the genetic and drug resistance profiles of MABC subtypes in tropical China using whole-genome sequencing.

## Key findings

- M. abscessus subsp. abscessus is the most prevalent subtype in Hainan, followed by M. abscessus subsp. massiliense.
- Mma shows significantly lower clarithromycin resistance compared to Mab, suggesting better treatment outcomes.
- Genetic analysis reveals high diversity and potential local transmission of MABC strains in the region.

## Abstract

Based on whole-genome sequencing (WGS) technology, the species distribution, genetic correlations, virulence and drug resistance gene characteristics of the clinical isolates of Mycobacterium abscessus complex (MABC) in the tropical island of China (Hainan) were analyzed to provide a basis for clinical precise diagnosis and treatment.

A total of 113 MABC strains from the Second Affiliated Hospital of Hainan Medical University from 2014 to 2023 were collected. Whole-genome sequencing (WGS) was used for subspecies identification (Average Nucleotide Identity, ANI), genetic distance analysis (single nucleotide polymorphism, SNP), and pan-genome analysis. The distribution of virulence and antibiotic resistance genes was analyzed through the Virulence Factor Database (VFDB) and the Comprehensive Antibiotic Resistance Database (CARD). The drug susceptibility phenotypes were detected by the microbroth dilution method.

Among the 113 MABC strains, M. abscessus subsp. abscessus (Mab) accounted for 65.5%, M. abscessus subsp. massiliense (Mma) accounted for 33.6%, and M. abscessus subsp. bolletii (Mbo) accounted for 0.9%. The strains showed high genetic diversity among them, but two pairs of Mab strains with high genetic similarity (differing by 5 and 8 SNPs respectively) were identified, suggesting the possibility of local common exposure. The pan-genome is open-ended and consists of 3,626 core genes and highly variable accessory/unique genes. The virulence genes show species-specific differences: the detection rate of the phenolic lipid synthesis gene papA5 in Mma is significantly higher than that in Mab (92.1% vs. 47.3%, p < 0.001), while the PDIM synthesis gene ppsE is significantly lower in Mma (0.0% vs. 98.6%, p < 0.001). The drug sensitivity test shows that the 14-day induction of resistance rate of Mma to clarithromycin is significantly lower than that of Mab (5.3% vs. 86.5%, p < 0.001). Resistance genes are widely carried, including rrs a1408g (99.1%), rrl a2059g (98.2%) mutations, and the efflux pump gene qacJ in Mma (97.4%).

In Hainan region, environmental exposure is the main source of MABC infection. Whole genome analysis suggests the potential risk of local common exposure. Mma has a better treatment prospect due to its low clindamycin resistance rate. The differentiation of virulence and resistance genes among subtypes provides a molecular basis for the precise prevention and control of MABC infection in tropical regions.

## Linked entities

- **Genes:** PAPA5 (Polydactyly, postaxial, type A5) [NCBI Gene 101241897], ppsE (phthiocerol synthesis polyketide synthase type I PpsE) [NCBI Gene 888210]
- **Chemicals:** clarithromycin (PubChem CID 84029), clindamycin (PubChem CID 446598)

## Full-text entities

- **Genes:** CAT (catalase) [NCBI Gene 847], MMD (monocyte to macrophage differentiation associated) [NCBI Gene 23531] {aka MMA, MMD1, PAQR11}, HSPD1 (heat shock protein family D (Hsp60) member 1) [NCBI Gene 3329] {aka CPN60, GROEL, HLD4, HSP-60, HSP60, HSP65}, GRIA1 (glutamate ionotropic receptor AMPA type subunit 1) [NCBI Gene 2890] {aka GLUH1, GLUR1, GLURA, GluA1, HBGR1, MRD67}, ELF3 (E74 like ETS transcription factor 3) [NCBI Gene 1999] {aka EPR-1, ERT, ESE-1, ESX}
- **Diseases:** pulmonary infection (MESH:D012141), Respiratory Diseases (MESH:D012140), drug-resistant tuberculosis (MESH:D018088), bronchiectasis (MESH:D001987), MABC (MESH:D009165), CL (MESH:D002971), pulmonary tuberculosis (MESH:D014397), NTM infections (MESH:D007239), lung diseases (MESH:D008171), Toxicity (MESH:D064420), CF (MESH:D003550), COPD (MESH:D029424), drug resistance (MESH:D000069279), Tuberculosis (MESH:D014376), NTM (MESH:D014390)
- **Chemicals:** lysA (-), CLR (MESH:D017291), cefoxitin (MESH:D002440), DOX (MESH:D004318), saline (MESH:D012965), mercury (MESH:D008628), aminoglycoside (MESH:D000617), penicillin (MESH:D010406), MAB (MESH:D000911), cephalosporins (MESH:D002511), cetyltrimethylammonium bromide (MESH:D000077286), Amino acid (MESH:D000596), AMC (MESH:D019980), macrolide (MESH:D018942), AK (MESH:D000583), mycolic acid (MESH:D009171), chlorine (MESH:D002713), CIP (MESH:D002939), Tigecycline (MESH:D000078304), lincosamides (MESH:D055231), LZD (MESH:D000069349), Rifamycin (MESH:D012294), rifampicin (MESH:D012293), IPM (MESH:D015378), water (MESH:D014867), citrate (MESH:D019343), clindamycin (MESH:D002981), vancomycin (MESH:D014640), glycopeptide (MESH:D006020), lipid (MESH:D008055), Iron (MESH:D007501), TMP-SMX (MESH:D015662), phthiocerol dimycocerosate (MESH:C008901), glutaraldehyde (MESH:D005976), glycolipids (MESH:D006017), beta-lactam (MESH:D047090), TOB (MESH:D014031), MFX (MESH:D000077266), telithromycin (MESH:C106791), sulfite (MESH:D013447), cholesterol (MESH:D002784), ROS (MESH:D017382)
- **Species:** Mycobacteroides abscessus (species) [taxon 36809], Mycobacteroides abscessus subsp. massiliense (subspecies) [taxon 1962118], Mycobacterium tuberculosis (species) [taxon 1773], Mycobacterium tuberculosis H37Rv (strain) [taxon 83332], Mycobacterium avium complex sp. (species) [taxon 37162], Homo sapiens (human, species) [taxon 9606], Syntermes sp. T42 (species) [taxon 2230741], Streptomyces sp. t99 (species) [taxon 1828172], Sinorhizobium sp. T23 (species) [taxon 617194], Mycobacteroides abscessus subsp. bolletii (subspecies) [taxon 319705]
- **Cell lines:** -110 — Homo sapiens (Human), Niemann-Pick disease, type C1, Finite cell line (CVCL_W054), Mab — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_M133)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913411/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913411/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913411/full.md

---
Source: https://tomesphere.com/paper/PMC12913411